# The Effects of Preoperative Bevacizumab on Perioperative Complications

> **NCT04788381** · — · UNKNOWN · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 100 (estimated)

## Conditions studied

- Colorectal Cancer
- Lung Cancer
- Operation Wound; Infection
- Bevacizumab

## Interventions

- **DRUG:** Bevacizumab

## Key facts

- **NCT ID:** NCT04788381
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-01
- **Primary completion:** 2021-05-31
- **Final completion:** 2021-07-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04788381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04788381, "The Effects of Preoperative Bevacizumab on Perioperative Complications". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04788381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
